Skip to main content
logo
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.19
+1.32 (4.91%)
At close: Feb 24, 2026, 4:00 PM EST
28.75
+0.56 (1.99%)
After-hours: Feb 24, 2026, 7:38 PM EST

HRMY Revenue

In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.

Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
1.87
Revenue / Employee
$3,240,496
Employees
268
Market Cap
1.62B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx407.32M
MannKind313.79M
Nurix Therapeutics83.98M
Intellia Therapeutics57.53M
Relay Therapeutics8.36M
AtaiBeckley3.02M
Celldex Therapeutics2.60M
Revenue Rankings

HRMY News

More News